FarmaKology’s Substack

Share this post

FarmaKology Newsletter - Issue #15

www.farmakology.com

FarmaKology Newsletter - Issue #15

FarmaKology
Jul 16, 2019
Share this post

FarmaKology Newsletter - Issue #15

www.farmakology.com

Today's Startup

BenevolentAI

BenevolentAI is the global leader in the development and application of artificial intelligence (“AI”) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases.

News

Faron Pharmaceuticals reports new data for cancer drug Clevegen

Faron Pharmaceuticals has reported new findings from the open-label Phase I/II MATINS clinical trial of its cancer immunotherapy Clevegen for the treatment of certain metastatic or inoperable solid tumours.Clevegen is an anti-Clever-1 antibody that can switch immune suppression to immune activation, with potential for application in oncology, infectious disease, and vaccine development.

Avicenna CEO Salim Jetha confirms deal with Juno

The Chief Executive Officer of Avicenna Pharmacy has confirmed that Juno Health has bought the independent pharmacy support group. Salim Jetha told Pharmacy Business on Friday that the acquisition is expected to benefit Avicenna members because Juno Health promises to continue “existing services with further investment to enhance these”.

Digital notification system helps pharmacists to support patients with mental illness

A digital communication system, which highlights patients who need extra support with antipsychotics and antidepressants, has been developed by Cheshire and Wirral Partnership NHS Trust and shown resounding success in pilot.

GSK's Zejula racks up first-line maintenance win in ovarian cancer, even in non-BRCA patients

GlaxoSmithKline laid out $5.1 billion last year for Tesaro and its key PARP inhibitor, Zejula, and with some new first-line ovarian cancer data, it has another chance to prove the deal was worth it.

Research & Study

New biomarker-guided strategy has potential for liver cancer treatment

Partnering with a pharmacist may decrease burnout among primary care providers

Scientists develop tumor-specific anti cancer therapy

Irish study may lead to new cancer treatments

Podcast

Stream Adherence Veterans Share Secrets: RxSafe Podcast Series Part Two - PPN Episode 831 by Pharmacy Podcast Network from desktop or your mobile device

Job Opportunities

Medical Representative

Pharmacy Technician

clinical pharmacist

Pharmacist

Video

Share this post

FarmaKology Newsletter - Issue #15

www.farmakology.com
Comments
TopNew

No posts

Ready for more?

© 2023 FarmaKology
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing